Attached files

file filename
10-K/A - AMENDED 10K - Vansen Pharma Inc.okanaform10kafinal.htm
EX-31 - CERTIFICATION - Vansen Pharma Inc.exhibit3110ka123109.htm

Exhibit 32

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)



In connection with the amended Annual Report of Okana Ventures, Inc., a Nevada corporation (the “Company”), on Form 10-K/A for the year ending December 31, 2009, as filed with the Securities and Exchange Commission (the “Report”), I, Michael Upham, President/Secretary/Treasurer/CEO/CFO of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that to my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




 /s/ Michael Upham                   

Michael Upham

President, Secretary, Treasurer, CEO, CFO


Dated:  March 9, 2010